Learn About Prothrombin Deficiency

What is the definition of Prothrombin Deficiency?

Prothrombin deficiency is a bleeding disorder that slows the blood clotting process. People with this condition often experience prolonged bleeding following an injury, surgery, or having a tooth pulled. In severe cases of prothrombin deficiency, heavy bleeding occurs after minor trauma or even in the absence of injury (spontaneous bleeding). Women with prothrombin deficiency can have prolonged and sometimes abnormally heavy menstrual bleeding. Serious complications can result from bleeding into the joints, muscles, brain, or other internal organs. Milder forms of prothrombin deficiency do not involve spontaneous bleeding, and the condition may only become apparent following surgery or a serious injury.

What are the causes of Prothrombin Deficiency?

Mutations in the F2 gene cause prothrombin deficiency. The F2 gene provides instructions for making the prothrombin protein (also called coagulation factor II), which plays a critical role in the formation of blood clots in response to injury. Prothrombin is the precursor to thrombin, a protein that initiates a series of chemical reactions to form a blood clot. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.

How prevalent is Prothrombin Deficiency?

Prothrombin deficiency is very rare; it is estimated to affect 1 in 2 million people in the general population.

Is Prothrombin Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Prothrombin Deficiency Local Doctors?
Elite in Prothrombin Deficiency
Elite in Prothrombin Deficiency
Sapporo, JP 

Masahiro Ieko practices in Sapporo, Japan. Mr. Ieko is rated as an Elite expert by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Prothrombin Deficiency, Acquired Hemophilia, Antiphospholipid Syndrome, and Blood Clots.

Advanced in Prothrombin Deficiency
Oncology | Hematology | Hematology Oncology
Advanced in Prothrombin Deficiency
Oncology | Hematology | Hematology Oncology

University Of Virginia Physicians Group

1240 Lee St, 
Charlottesville, VA 
Languages Spoken:
English, Mandarin
Accepting New Patients
Offers Telehealth

Louise Man is an Oncologist and a Hematologist in Charlottesville, Virginia. Dr. Man is rated as an Advanced provider by MediFind in the treatment of Prothrombin Deficiency. Her top areas of expertise are Pulmonary Embolism, Hemophilia B, Antiphospholipid Syndrome, and Von Willebrand Disease (VWD). Dr. Man is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Prothrombin Deficiency
Cardiac Electrophysiology | Cardiology
Advanced in Prothrombin Deficiency
Cardiac Electrophysiology | Cardiology

Spectrum Health Primary Care Partners

602 Michigan Ave, Suite 102, 
Holland, MI 
Languages Spoken:
English, Arabic
Accepting New Patients

Musa Dahu is a Cardiac Electrophysiologist and a Cardiologist in Holland, Michigan. Dr. Dahu is rated as an Advanced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Pacemaker Implantation, and Cardiac Ablation. Dr. Dahu is currently accepting new patients.

What are the latest Prothrombin Deficiency Clinical Trials?
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.

Summary: Primary purpose : Compare the sensitivity of several thromboplastin reagents of various origins to prothrombin time and factor II, V, VII and X assays in two different populations of patients : * Patients with an isolated extrinsic pathway deficiency (acquired or congenital) of factor II or V or VII or X. * Patients with an hepatocellular insufficiency generally associated with coagulopathy (with ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: November 01, 2013
Published By: National Institutes of Health